Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$114.22 - $140.1 $175,898 - $215,754
1,540 New
1,540 $213,000
Q1 2022

May 10, 2022

SELL
$94.08 - $130.2 $36,220 - $50,126
-385 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$106.71 - $143.18 $41,083 - $55,124
385 New
385 $211,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Private Harbour Investment Management & Counsel, LLC Portfolio

Follow Private Harbour Investment Management & Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Harbour Investment Management & Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Harbour Investment Management & Counsel, LLC with notifications on news.